InsidersTradesSigma
광동제약 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 광동제약 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Food & Beverage sector, 광동제약 has recorded 42 public disclosures. Market capitalisation: €300bn. The latest transaction was reported on 14 April 2026 (Other). Among the most active insiders: 최성원. All data is openly available.
41
Insider Decl.
n/a
Thresholds
€76,292
7 ops.
Buy Volume
n/a
1 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,784 of 28,169 companies
50.6
score / 100
Value74
Quality27
FCF yld17%
Earn yld6.5%
EV/EBITDA10.4x
ROE3.3%
Gross mgn18%
Net mgn1.3%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 14 April 2026
Declarations42 total
Other
Other(filed)
25 of 42 declarations
About 광동제약
광동제약 is a South Korean company that specializes in the manufacturing of pharmaceutical and health products. It is listed on the XKRX market.